Lysyl oxidase
Lysyl oxidase (LOX) is an enzyme that plays a crucial role in the biosynthesis of collagen and elastin. It is a copper-dependent amine oxidase that catalyzes the cross-linking of collagen and elastin in the extracellular matrix, which is essential for the structural integrity and function of various tissues.
Function[edit | edit source]
Lysyl oxidase initiates the formation of covalent cross-links in collagen and elastin by oxidizing the ε-amino group of lysine residues to form reactive aldehydes. These aldehydes then undergo spontaneous chemical reactions to form cross-links, which stabilize the extracellular matrix and contribute to the mechanical properties of tissues such as skin, bone, and blood vessels.
Structure[edit | edit source]
The enzyme is synthesized as a precursor molecule, known as pro-lysyl oxidase, which undergoes proteolytic processing to become the active enzyme. The active form of lysyl oxidase contains a copper ion at its active site, which is essential for its catalytic activity. The enzyme also contains a lysine tyrosylquinone (LTQ) cofactor, which is formed by the post-translational modification of a lysine and a tyrosine residue.
Genetics[edit | edit source]
The gene encoding lysyl oxidase is located on chromosome 5 in humans. Mutations in the LOX gene can lead to various connective tissue disorders due to the impaired cross-linking of collagen and elastin.
Clinical Significance[edit | edit source]
Lysyl oxidase is implicated in several pathological conditions. Overexpression of LOX has been associated with fibrosis, where excessive cross-linking of collagen leads to tissue stiffening and scarring. Conversely, reduced LOX activity is linked to conditions such as Menkes disease, a disorder of copper metabolism that results in defective collagen and elastin cross-linking.
Research and Therapeutic Potential[edit | edit source]
Given its role in tissue remodeling and repair, lysyl oxidase is a target of interest in the development of therapies for fibrotic diseases, cancer, and other conditions involving extracellular matrix abnormalities. Inhibitors of LOX are being explored as potential treatments for fibrosis and cancer metastasis.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD